Diabetes Drugmaker

'Diabetes Drugmaker' - 8 News Result(s)

  • Google Parent Alphabet and French Drugmaker Sanofi Set Up Diabetes Joint Venture
    Agence France-Presse | Monday September 12, 2016
    The venture, called Onduo, will initially focus on type two diabetes, the more common form of the disease.
    gadgets.ndtv.com
  • Sanofi, Google Parent In $500 Million Diabetes Joint Venture
    Business | Reuters | Monday September 12, 2016
    French drugmaker Sanofi and Google owner Alphabet's U.S-based life sciences company Verily, announced on Monday the launch of a joint-venture aimed at offering patients suffering from diabetes products that will combine devices and services.
    www.ndtv.com/business
  • Drugmaker Cipla Pushes into US With Two Deals
    Business | Thomson Reuters | Friday September 4, 2015
    India's fourth-largest drugmaker by sales will buy privately-held firms InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc, gaining multiple products in the areas of anti-infectives, diabetes and central nervous system disorders.
    www.ndtv.com/business
  • Novartis and Google to Develop 'Smart' Contact Lens
    World News | Reuters | Tuesday July 15, 2014
    Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus.
    www.ndtv.com
  • India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
    India News | Reuters | Monday July 14, 2014
    India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
    www.ndtv.com
  • Drugmaker Novartis files patent suit against Biocon over diabetes drug
    Business | Thursday April 3, 2014
    Novartis has taken Biocon to court for infringing the patent on its diabetes drug Galvus, the Swiss drugmaker said in a statement on Thursday.
    www.ndtv.com/business
  • Cadila health to market new diabetes drug in India
    Business | Wednesday June 5, 2013
    Cadila, India's sixth-largest drugmaker by sales, spent $250 million developing Lipaglyn, a new chemical entity or new discovery, and aims to spend another $150 million to $200 million to launch the drug outside India, the company's chairman, Pankaj Patel, said.
    www.ndtv.com/business
  • World News | Gardiner Harris, NYT News Service | Tuesday July 13, 2010
    In the fall of 1999, the drug giant SmithKline Beecham secretly began a study to find out if its diabetes medicine, Avandia, was safer for the heart than a competing pill, Actos, made by Takeda. Avandia's success was crucial to SmithKline, whose labs were otherwise all but barren of new products. But the study's results, completed that same year, w...
    www.ndtv.com

'Diabetes Drugmaker' - 8 News Result(s)

  • Google Parent Alphabet and French Drugmaker Sanofi Set Up Diabetes Joint Venture
    Agence France-Presse | Monday September 12, 2016
    The venture, called Onduo, will initially focus on type two diabetes, the more common form of the disease.
    gadgets.ndtv.com
  • Sanofi, Google Parent In $500 Million Diabetes Joint Venture
    Business | Reuters | Monday September 12, 2016
    French drugmaker Sanofi and Google owner Alphabet's U.S-based life sciences company Verily, announced on Monday the launch of a joint-venture aimed at offering patients suffering from diabetes products that will combine devices and services.
    www.ndtv.com/business
  • Drugmaker Cipla Pushes into US With Two Deals
    Business | Thomson Reuters | Friday September 4, 2015
    India's fourth-largest drugmaker by sales will buy privately-held firms InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc, gaining multiple products in the areas of anti-infectives, diabetes and central nervous system disorders.
    www.ndtv.com/business
  • Novartis and Google to Develop 'Smart' Contact Lens
    World News | Reuters | Tuesday July 15, 2014
    Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus.
    www.ndtv.com
  • India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
    India News | Reuters | Monday July 14, 2014
    India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
    www.ndtv.com
  • Drugmaker Novartis files patent suit against Biocon over diabetes drug
    Business | Thursday April 3, 2014
    Novartis has taken Biocon to court for infringing the patent on its diabetes drug Galvus, the Swiss drugmaker said in a statement on Thursday.
    www.ndtv.com/business
  • Cadila health to market new diabetes drug in India
    Business | Wednesday June 5, 2013
    Cadila, India's sixth-largest drugmaker by sales, spent $250 million developing Lipaglyn, a new chemical entity or new discovery, and aims to spend another $150 million to $200 million to launch the drug outside India, the company's chairman, Pankaj Patel, said.
    www.ndtv.com/business
  • World News | Gardiner Harris, NYT News Service | Tuesday July 13, 2010
    In the fall of 1999, the drug giant SmithKline Beecham secretly began a study to find out if its diabetes medicine, Avandia, was safer for the heart than a competing pill, Actos, made by Takeda. Avandia's success was crucial to SmithKline, whose labs were otherwise all but barren of new products. But the study's results, completed that same year, w...
    www.ndtv.com
Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com